Anaxiom is a privately held medical device company focused on developing minimally invasive technologies for the treatment of obesity.  

Obesity is one of the most important public health problems in the world today, impacting more than one billion people worldwide and more than 109 million adults in the United States alone.  It is a chronic and complex disease that if left untreated can lead to serious health consequences and premature death.  

Anaxiom has developed a novel implatable device to selectively modulate blood flow leading to controlled weight loss utilizing a conventional percutaneous approach. 

At Anaxiom we are dedicated to providing innovative solutions to help people struggling with obesity.